- 1 Introduction
- 2 Pathogenesis of urinary tract infections
- 3 Aetiology and antimicrobial resistance of uropathogens
- 4 Antibiotic usage and stewardship
- 5 Classification of urinary tract infections
- 6 Asymptomatic bacteriuria (ABU)
- 7 Uncomplicated urinary tract infections (uUtI)
- 8 Recurrent (uncomplicated) urinary tract infections
- 9 Urinary tract infections with extraurogenital risk factors
- 10 Urinary tract infections with renal risk factors
- Polycystic renal disease
- Antibiotic therapy in patients with renal impairment
- Urinary tract infections in patients with renal insufficiency and dialysis – epidemiology, pathogenesis, clinical symptoms, diagnosis and treatment
- Urinary tract infections in children with chronic kidney disease
- Biomarkers in children with kidney diseases
- UTI in renal transplant patients
- Viral urological infections in kidney transplantation: BK polyomavirus (BKPyV)-associated diseases
- 11 Urinary tract infections with (transient) urological risk factors
- 12 Urinary tract infections with permanent urological risk factors
- 13 Device related urinary tract infections
- 14 Urinary tract infections in children
- 15 Urogenital infections during pregnancy
- 16 Nosocomial and health-care associated urinary tract infections
- Healthcare-associated urinary tract infections in urology
- Observational study over 8-year period evaluating microbiological characteristics and risk factor for isolation of multidrug-resistant organisms (MDRO) in patients with healthcare-associated infections (HAIs) hospitalized in a urology ward in Urogenital Infections and Inflammations
- 17 Urosepsis
- 18 Prevention of infections associated with urological interventions
- 19 Male accessory gland and genital infections and inflammations
- 20 Chronic prostatis/chronic pelvic pain syndrome
- Definition and epidemiology of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
- Etiology of chronic prostatitis/chronic pelvic pain syndrome – How animal models guide understanding of the syndrome
- Evaluation of chronic prostatitis/chronic pelvic pain syndrome
- Treatment of chronic prostatitis/chronic pelvic pain syndrome – UPOINT
- Quality of life and relationships in chronic prostatitis/chronic pelvic pain syndrome: models of self-regulation and psychosocial risk factors
- 21 Interstitial cystitis/chronic bladder pain syndrome
- Comprehensive neuromuscular assessment of chronic pelvic pain (including BPS/IC)
- Bladder pain syndrome: differences in diagnostic strategies around the world
- Clinical features and histopathologic findings in BPS/IC with and without Hunner’s lesions
- Invasive therapy for bladder pain syndrome/interstitial cystitis (BPS/IC)
- Patient contributions to treatment decisions in BPS/IC
- 22 Gynecological urogenital infections
- 23 Sexually transmitted urogenital infections (STI)
- 24 Urogenital tuberculosis and atypical mycobacterial urogenital infections
- Microbiology and resistance in urogenital tuberculosis
- Epidemiology, classification, clinical features, and diagnostics of urogenital tuberculosis
- Medical treatment for urogenital tuberculosis (UGTB)
- Surgical treatment of urogenital tuberculosis
- Tuberculosis as a reason for male and female sexual dysfunction
- BCG infections
- Rare cases of urogenital tuberculosis and atypical mycobacterial urogenital infection
- Urogenital tuberculosis as a part of extrapulmonary tuberculosis in two epidemic regions
- 25 Other urogenital infections (including viral infections)
- 26 The microbiome of the urogenital tract
- 27 Current and future antibiotics for urogenital tract infections
ZB MED is a member of DataCite
DataCite is an international not-for-profit organisation that offers services and know-how relating to the management, referencing and citation of research data.
ZB MED advocates gender equality
ZB MED received the TOTAL E-QUALITY award in 2010 and 2013 for successfully implementing gender equality in its staffing structure and personnel policies.
Award for German Medical Science
German Medical Science (GMS) was awarded the distinction of "Selected landmark 2011" in the "Germany - Land of Ideas" initiative.
ZB MED advocates Open Access
ZB MED promotes and supports open access to scientific research through the PUBLISSO portal and other services.